| Literature DB >> 34281189 |
Wojciech Bocian1, Elżbieta Bednarek1, Katarzyna Michalska2.
Abstract
Molecular modeling (MM) results for tedizolid and radezolid with heptakis-(2,3-diacetyl-6-sulfo)-β-cyclodextrin (HDAS-β-CD) are presented and compared with the results previously obtained for linezolid and sutezolid. The mechanism of interaction of chiral oxazolidinone ligands belonging to a new class of antibacterial agents, such as linezolid, tedizolid, radezolid, and sutezolid, with HDAS-β-CD based on capillary electrokinetic chromatography (cEKC), nuclear magnetic resonance (NMR) spectroscopy, and MM methods was described. Principles of chiral separation of oxazolidinone analogues using charged single isomer derivatives of cyclodextrin by the cEKC method were presented, including the selection of the optimal chiral selector and separation conditions, complex stoichiometry, and binding constants, which provided a comprehensive basis for MM studies. In turn, NMR provided, where possible, direct information on the geometry of the inclusion complexes and also provided the necessary structural information to validate the MM calculations. Consequently, MM contributed to the understanding of the structure of diastereomeric complexes, the thermodynamics of complexation, and the visualization of their structures. The most probable mean geometries of the studied supramolecular complexes and their dynamics (geometry changes over time) were determined by molecular dynamics methods. Oxazolidinone ligands have been shown to complex mainly the inner part of cyclodextrin, while the external binding is less privileged, which is consistent with the conclusions of the NMR studies. Enthalpy values of binding of complexes were calculated using long-term molecular dynamics in explicit water as well as using molecular mechanics, the Poisson-Boltzmann or generalized Born, and surface area continuum solvation (MM/PBSA and MM/GBSA) methods. Computational methods predicted the effect of changes in pH and composition of the solution on the strength and complexation process, and it adapted the conditions selected as optimal during the cEKC study. By changing the dielectric constant in the MM/PBSA and MM/GBSA calculations, the effect of changing the solution to methanol/acetonitrile was investigated. A fairly successful attempt was made to predict the chiral separation of the oxazolidinones using the modified cyclodextrin by computational methods.Entities:
Keywords: NMR; chiral cEKC; molecular modeling; non-covalent interactions; oxazolidinone
Mesh:
Substances:
Year: 2021 PMID: 34281189 PMCID: PMC8268345 DOI: 10.3390/ijms22137139
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Molecular structures of linezolid (LIN), tedizolid (TED), radezolid (RAD), and sutezolid (STD). The LIN, TED, RAD, and STD precursors are marked in the frame.
Summary of the fundamental parameters obtained in the cEKC studies and experimental values of binding constants for HDAS-β-CD.
| Analyte | Type of BGE | Separation Conditions | EMO Reversal for a Leading Compound | Ref. | Method of Determination of Binding Constant | pH | Binding Constant Ka * | Ref. | |
|---|---|---|---|---|---|---|---|---|---|
| -( | -( | ||||||||
| LIN leading | ACE | 27.5 mM HDAS-β-CD in 50 mM borate buffer, | 18.75 mM HDAS-β-CD in 50 mM borate buffer, pH 8.0, 15 °C, capillary (2), RP, | [ | NMR diffusion, | 2.4 |
| 66 ± 5 | [ |
| 7.0 |
| 35 ± 2 | |||||||
| LIN | ACE | 37.5 mM HDAS-β-CD in 50 mM formic buffer, pH 4.0 with ACN (81.4:18.6, | not observed | [ | cEKC | 4.0 | 1311 ± 256 |
| [ |
| 9.0 | 571 ± 80 |
| |||||||
| TED | 4.0 |
| 728 ± 145 | ||||||
| 9.0 | 319 ± 51 |
| |||||||
| TED | - | - | - | NMR diffusion, | - | 140 | - | [ | |
| TED-PO4 | - | 98 ± 20 | - | ||||||
| LIN | ACE | 6 mM HDAS-β-CD in 50 mM phosphoric buffer, pH 2.5, capillary (1), 28 kV, 17–27 °C, NP | 18 mM HDAS-β-CD in 50 mM phosphate buffer, pH 6.6, 27 °C, capillary (1), NP | [ | cEKC | 2.5 | 41.5 ± 10 |
| [ |
| 6.6 | 45.8 ± 10 |
| |||||||
| RAD | 20 mM HDAS-β-CD in 50 mM phosphoric buffer, pH 2.5, capillary (1), 28 kV, 52 °C, RP (partial resolution) | 2.5 |
| 2817 ± 600 | |||||
| 6.6 | 999 ± 200 |
| |||||||
| LIN | NACE | not observed with HDAS-β-CD | 45 mM HDMS-β-CD in MeOH/ACN (85:15, | [ | nd | nd | nd | - | |
| STD | 5 mM HDAS-β-CD in MeOH/ACN (85:15, | ||||||||
Capillary (1)—uncoated fused silica capillary, capillary (2) neutral-coated capillary—zero EOF flow, NP—normal polarity, RP—reversed polarity, nd—not detected, * for the cEKC method, Ka is the apparent binding constant since the viscosity and the exact ionic strength of the buffer, which is affected by the increase in charged CD concentration, were not included in the calculations. The highest binding values are shown in bold.
Figure 2Schematic representation of TED, RAD, SUT [12], and LIN [5] complexes with HDAS-β-CD.
Figure 3Representative conformations from the most probable cluster based on RMSD of the TED and RAD complexes with HDAS-β-CD.
Calculated binding average energies (enthalpies) for oxazolidinones complexes with HDAS-β-CD. Averages are calculated only for the time intervals marked in bold in Figure 4.
| Compound | Average Binding Enthalpies [kcal/mol] (b) | |||||||
|---|---|---|---|---|---|---|---|---|
| StrA | StrB | StrC | ||||||
| H2O | MeOH/ACN | H2O | MeOH/ACN | H2O | ||||
| MD | PBSA | PBSA | MD | PBSA | PBSA | MD | PBSA | |
| LIN-( | − | −21.6 ± 4.8 | − | − | −26.4 ± 4.5 | - | - | - |
| LIN-S (a) | − | −21.7 ± 5.0 | − | − | 24.7 ± 3.8 | - | - | - |
| TED-( | −21.3 ± 1.7 | −16.2 ± 0.2 | −16.4 ± 0.2 | −21.4 ± 1.2 | −22.9 ± 1.0 | −23.2 ± 1.1 | −17.5 ± 2.2 | −10.6 ± 2.8 |
| TED-( | −21.4 ± 1.5 | −16.1 ± 0.4 | −16.4 ± 0.4 |
|
|
| - | - |
| RAD-( | −23.4 ± 0.3 | −28.6 ± 0.3 | −29.3 ± 0.2 | −23.6 ± 0.8 | −28.2 ± 0.7 | −29.1 ± 0.7 | −21.9 ± 1.9 | −17.2 ± 2.2 |
| RAD-( |
|
| −31.2 ± 0.4 | −23.8 ± 0.6 | 27.0 ± 3.8 | 27.8 ± 4.1 | - | - |
| RADprot-( | −26.6 ± 0.9 | −26.6 ± 0.5 | −30.8 ± 0.7 |
| −33.3 ± 0.8 | −40.6 ± 0.8 | −20.2 ± 3.2 | −16.4 ± 1.8 |
| RADprot-( | −27.1 ± 0.6 | −31.3 ± 0.5 | −35.8 ± 0.7 | −27.5 ± 0.8 |
| −41.3 ± 0.8 | - | - |
| STD (a) | −18.9 ± 0.7 | −23.4 ± 0.7 | −24.1 ± 0.7 | −20.2 ± 0.8 | −25.8 ± 2.1 | −26.6 ± 2.1 | −16.5 ± 1.1 | −5.5 ± 4.0 |
| STDprot (a) | −18.8 ± 0.7 | −23.8 ± 0.9 | −24.3 ± 1.2 | −19.9 ± 0.6 | −26.2 ± 1.0 | −32.8 ± 1.1 | - | - |
(a) Calculation results taken from the previously published work for STD [12] and for LIN [5]. (b) The lowest energies for oxazolidinones complexes are shown in bold.
Figure 4Energy changes during molecular dynamics simulations. The simulation ranges from which the average energies were calculated are shown in bold in Table 2.
Figure 5Changes in the distances Δh (and its standard deviations SD(h)) between the asymmetric carbon atom of oxazolidinone and the plane intersecting the centers of the cyclodextrin sugar rings during MD calculations.
Intermolecular hydrogen bonds (H-bonds) in oxazolidinone–HDAS-β-CD complexes.
| Complex | Intermolecular H-Bonds | |||
|---|---|---|---|---|
| Name | Av. Distance [Å] | Population | Av. H-Bonds No. | |
| StrA–TED | - | - | No | 0 |
| StrB–TED | - | - | No | 0 |
| StrA–RAD | RAD-N(1) | 2.29 +/− 0.47 | High | 1.30 ( |
| RAD-N(3) | 2.24 +/− 0.34 | High | ||
| RAD-N(4) | 2.17 +/− 0.30 | High | ||
| RAD-N(4) | 2.29 +/− 0.34 | Mid | ||
| RAD-N(3) | 2.60 +/− 0.28 | Mid | ||
| RAD-N(3) | 2.57 +/− 0.31 | Mid | ||
| RAD-N(3) | 2.75 +/− 0.30 | Low | ||
| StrB–RAD | RAD-N(4) | 2.24 +/− 0.35 | High | 2.08 ( |
| RAD-N(3) | 2.30 +/− 0.35 | High | ||
| RAD-N(3) | 2.44 +/− 0.31 | Mid | ||
| RAD-N(4) | 2.39 +/− 0.31 | Mid | ||
| RAD-N(4) | 2.44 +/− 0.29 | Low | ||
| StrA–RADprot | RADprot-N(1) | 2.29 +/− 0.46 | High | 1.94 ( |
| RADprot-N(3) | 2.12 +/− 0.28 | High | ||
| RADprot-N(3) | 2.18 +/− 0.35 | High | ||
| RADprot-N(3) | 2.14 +/− 0.29 | High | ||
| RADprot-N(3) | 2.08 +/− 0.23 | High | ||
| RADprot-N(4) | 2.12 +/− 0.28 | Mid | ||
| RADprot-N(4) | 2.22 +/− 0.32 | Mid | ||
| StrB–RADprot | RADprot-N(3) | 2.27 +/− 0.37 | High | 3.25 ( |
| RADprot-N(3) | 2.23 +/− 0.35 | High | ||
| RADprot-N(4) | 2.23 +/− 0.37 | High | ||
| RADprot-N(1) | 2.23 +/− 0.41 | Low | ||
| (*) | (*) | (*) | ||
(*) H-bond created in 12 µs of simulation for the StrB–RADprot(S) complex.